1. Duke University-$132,000 over two years. "Oncolytic Immunotherapy of Glioblastoma with Recombinant Poliovirus".

The award is for part of this major project that the FDA required to look closer at some inflammatory markers. This project is one of the most exciting and promising studies in brain cancer research with potential to be used in other cancers. See this video to learn more.

2. Cleveland Clinic Foundation-$150K over two years. "Targeting Myeloid Derived Suppressor Cells To Reverse Immune Suppression and Glioblastoma Growth With the use of 5FU".

Using a low dose of this FDA approved drug has great potential in strengthening the immune system and killing glioma cancer growth. See this video to learn more.

3. Case Comprehensive Cancer Center-$68K over two years."Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma".

This is a study of a very tolerable ketogenic diet being used in combination with an FDA approved drug. There is evidence that a ketogenic diet can help kill certain cancer cells. Combining it with this FDA approved drug to treat glioblastoma theoretically will result in better outcomes than using either alone.

4. Case Comprehensive Cancer Center-$70K over two years."Computational Identification and Validation of Multi-Omic Correlates of Therapeutic Response for Glioblastoma".

Computerized technique developed at Case that has successfully identified potential treatments for triple negative breast cancer. This same technique will search international databases for evidence that certain FDA approved drugs can have therapeutic benefit against GBM. This can lead to successful combination treatments.